Alkalosis: Clinical Trials

3 trials for Alkalosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1
Phase 21Terminated 1

Follow Alkalosis: new trials by email Literature Review of Alkalosis trials Research Report on Alkalosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chronic Versus Acute Dosing of Sodium Citrate for Swimming 200m
Sodium Citrate Dihydrate - Alkalosis
Phase 3CompletedBrock University102012-09-012014-07-24
Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Carbogen, Placebo - Febrile Seizure
Phase 2 / Phase 3TerminatedCharite University, Berlin, Germany962012-08-012018-01-26
Treatment of Metabolic Alkalosis With Acetazolamide. Effect on the Length of Mechanical Ventilation.
Acetazolamide, Placebo - Pulmonary Disease, Chronic Obstructive, Obesity Hypoventilation Syndrome
Phase 3CompletedHospital Son Llatzer1402011-11-012015-03-17

Narrower conditions

Alkalosis, Respiratory (1)  ·  Obesity Hypoventilation Syndrome (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Aspiration (1)  ·  Seizures, Febrile (1)

Broader conditions

Acid-Base Imbalance (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Nervous System Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiration Disorders (2)  ·  Respiratory Tract Diseases (2)  ·  Apnea (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Dyssomnias (1)  ·  Hyperventilation (1)  ·  Hypoventilation (1)  ·  Lung Diseases (1)

Interventions

Acetazolamide (1)  ·  Oxygen (1)  ·  Sodium Citrate (1)  ·  carbogen (1)

Sponsors

Brock University (1)  ·  Charite University, Berlin, Germany (1)  ·  Hospital Son Llatzer (1)

Countries

Canada (1)  ·  Germany (1)  ·  Spain (1)

Top investigators

Nota Klentrou, PhD (1)

Results publications

PMID 24944546, PMID 28286047, PMID 41433250